-
Optimer ligands are
short synthetic oligonucleotide molecules composed of DNA or RNA that bind to a
specific target molecule. They are
engineered to bind...
-
Optimer Pharmaceuticals Inc (Nasdaq: OPTR) was a
biopharmaceutical company,
originally headquartered in San Diego, California, and
later moved to Jersey...
-
Pharmaceuticals in 2015, and had in turn
bought the
originating company,
Optimer Pharmaceuticals. It is used for the
treatment of
Clostridioides difficile...
- 2013,
Cubist Pharmaceuticals agreed to
purchase Trius Therapeutics and
Optimer Pharmaceuticals for
around $1.6 billion. In 2014,
succeeding Michael Bonney...
- 29, 2002. It was
formerly a
subsidiary of
Optimer Pharmaceuticals. On 9 Feb 2007, its
parent company Optimer Pharmaceuticals can buy/sell on
Nasdaq Stock...
-
countries through a profit-sharing
arrangement with Biocon.
Biocon and
Optimer Pharmaceuticals, a
biopharmaceutical company focused on the
treatment of...
-
Magnetic immuno****ay
Microantibody Monoclonal antibody Neutralizing antibody Optimer Ligand Secondary antibodies Single-domain
antibody Slope spectroscopy Surrobody...
-
Maven Corporation Cubist Pharmaceuticals Trius Therapeutics (Acq 2013)
Optimer Pharmaceuticals (Acq 2013)
OncoEthix (Acq 2015)
IOmet Pharma (Acq 2016)...
- to
Nippon Shinyaku for prulifloxacin. It was not
until June 2004, when
Optimer Pharmaceuticals acquired exclusive rights to discover,
develop and commercialize...
- Pharmaceuticals, Verizon,
FedHome Loan Centers,
Google Inc.,
Texas Instruments,
Optimer Pharmaceuticals, The
ACTIVE Network,
Advanced Test
Equipment Rentals, Forcepoint...
